Jesús GabrielAltamirano (Gabriel)

Partner

Mexico City + 52.55.3000.4069

Gabriel Altamirano is recognized as a leading antitrust practitioner in Mexico. He has more than 20 years of experience representing foreign and domestic clients in a wide range of industries in all aspects related to antitrust, including merger control filings, investigations, and compliance.

In transactions, he represents clients before the Mexican competition authorities to obtain regulatory clearance for mergers and acquisitions and joint ventures. On the investigation side, Gabriel advises clients regarding investigations for anticompetitive agreements and practices, including cartels and abuses of a dominant position. He also advise clients in the implementation of compliance programs related to antitrust matters. In addition, Gabriel has extensive experience advising clients on banking, commercial, and energy matters, as well as in M&A transactions.

In recent years, Gabriel has represented clients in a broad range of industries, such as Arendal, Banco del Bajío, Cardinal Health, Grupo Gigante, Iberdrola, Koch Industries, Newell Rubbermaid, Office Depot de Mexico, Procter & Gamble, and Scotiabank.

Gabriel regularly speaks at conferences and publishes articles on competition law and government regulation. He is consistently ranked in Legal 500 and Who's Who Legal Mexico.

Experience

  • The Duchossois Group agrees to sell The Chamberlain Group LLC to BlackstoneJones Day is advising The Duchossois Group, Inc. in the sale of The Chamberlain Group LLC, a global leader in smart access solutions, to private equity funds managed by Blackstone.
  • Eaton sells hydraulics business to DanfossJones Day advised Eaton Corporation as antitrust counsel in the sale of its hydraulics business to Danfoss Power Solutions for US$3.3 billion.
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health on the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • Sanofi sells eight brands to Hypera PharmaJones Day is advising Sanofi in the sale to Hypera of 12 over-the-counter and prescription brands in Brazil, Colombia and Mexico, including mouth wash Cepacol and antipyretic AAS.
  • Cooper Tire & Rubber sold to The Goodyear Tire & Rubber Company for approximately $2.5 billion enterprise valueJones Day advised Cooper Tire & Rubber Company in its $2.5 billion sale to The Goodyear Tire & Rubber Company.
  • Ravago acquires IndukernJones Day served as competition counsel for Ravago S.A. in the acquisition of Indukern, a family owned distributor of specialty chemicals based in Spain, with a clear focus on the food, flavors & fragrances, pharma and animal nutrition application areas.
  • Entravision Communications acquires majority stake in RedmasJones Day represented Entravision Communications Corporation (NYSE: EVC) in the acquisition of a 51% interest in Redmas owned by the Cisneros Interactive Group.
  • International chemicals producer reviews antitrust aspects of transactionJones Day is providing antitrust counsel to an international chemicals producer in a multi-national merger control matter.
  • OYO partners with SoftBank Group to manage Latin American hotels businessJones Day is advising OYO in a joint venture with SoftBank Group to manage its Latin American hotels business.
  • NVIDIA acquires Mellanox Technologies for approximately $7 billionJones Day advised NVIDIA Corporation in its acquisition of Mellanox Technologies, Ltd., an Israel-based leading supplier of end-to-end InfiniBand and Ethernet interconnect solutions and services for servers and storage.
  • Grupo Gigante acquires El FarolitoJones Day advised Grupo Gigante, S.A.B. de C.V. in its acquisition of El Farolito, a taqueria chain.
  • Eaton sells lighting business to SignifyJones Day represented Eaton Corporation as antitrust counsel in the sale of its Cooper Lighting business to Signify N.V. (formerly known as Philips Lighting) for $1.4 billion.
  • Sanofi sold pack of OTC brands to Laboratorios SanferJones Day advised Sanofi in the sale to Laboratorios Sanfer of eye drops Irix in Argentina, the antiseptic Isodine in Mexico and Colombia, and the anti-inflammatory Lonol in Mexico.
  • USG acquired by Gebr. Knauf for $7 billionJones Day advised USG Corporation in the acquisition by Gebr. Knauf KG ("Knauf") of all of the outstanding shares of USG in a transaction valued at $7 billion.
  • Procter & Gamble acquires consumer health business of Merck KGaAJones Day advised The Procter & Gamble Company (“P&G”) in its €3.375 billion ($4.2 billion) acquisition of the worldwide consumer health business of Merck KGaA.
  • Alta Growth Capital and Abraaj Mexico Advisers acquire majority stock of DocuformasJones Day advised Alta Growth Capital and Abraaj Mexico Advisers, S.A. de C.V. in connection with the acquisition of the majority of the stock of Docuformas, S.A.P.I. de C.V., that induced a subsequent increase of capital by Abraaj.
  • Selmec Equipos Industriales acquired by Generac HoldingsJones Day advised Enesa, S.A. de C.V. in its sale of 100 percent of the shares of Selmec Equipos Industriales, S.A. de C.V., a manufacturer and designer of power plants of up to 2,750 kW, to Generac Holdings Inc. through its subsidiary in Mexico Ottomotres S.A. de C.V.
  • Fairmount Santrol and Unimin merge creating CoviaJones Day advised Fairmount Santrol in its merger with Unimin Corporation, a wholly owned subsidiary of SCR-Sibelco NV, in a tax-free, cash and stock transaction, creating a leader in proppant and industrial materials solutions.
  • Patrón Tequila acquired by BacardiJones Day advised Patrón Spirits International AG ("Patrón") in connection with the acquisition by Bacardi Limited of all of the issued and outstanding shares of Patrón.
  • Grupo Aeroportuario de la Ciudad de México completes MXN$30 billion IPO of Fibra E Shares on Mexican Stock ExchangeJones Day advised Grupo Aeroportuario de la Ciudad de México, S.A. De C.V. in connection with its MXN$30 billion (US$1.6 billion) initial public offering of Fibra E Shares on the Mexican Stock Exchange.